Influenza Vaccine(Split Virion), Inactivated, Quadrivalent (Anhui Zhifei Longcom Biologic Pharmacy)

四价流感病毒裂解疫苗（智飞龙科马生物制药）

Report date: 2025/03/21 16:14:27

Base Information

Drug NameInfluenza Vaccine(Split Virion), Inactivated, Quadrivalent (Anhui Zhifei Longcom Biologic Pharmacy)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2025/03/18
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A